Quicksilver Resources Inc. (NYSE:KWK) announced that the company completed its semi-annual redetermination and closed an amendment to its Combined Credit Agreements on April 25, 2014. Quicksilver Resources Inc (NYSE:KWK) shares after opening at $3.09 moved to $3.29 on last trade day and at the end of the day closed at $3.28 . Company price to sales ratio in past twelve months was calculated as 1.03 and price to cash ratio as 2.27. Quicksilver Resources Inc (NYSE:KWK) showed a positive weekly performance of 4.13%.
ChannelAdvisor Corporation (NYSE:ECOM) a leading provider of cloud-based e-commerce solutions that enable retailers and manufacturers to increase global sales, recently introduced the industry’s first portfolio bidder designed specifically for retailers. The ChannelAdvisor Portfolio Bidder automatically adjusts bids within retailers’ campaigns and ad groups to help increase ROI using a proprietary algorithm to predict traffic and revenue metrics at various possible keyword ranks. ChannelAdvisor customers using the Portfolio Bidder have experienced as much as a 300 percent lift in conversion rates. ChannelAdvisor Corp (NYSE:ECOM) shares fell -9.48% in last trading session and ended the day on $23.49. ChannelAdvisor Corp (NYSE:ECOM) return on equity ratio is recorded as -36.90% and its return on assets is -18.10%.
GW Pharmaceuticals plc – ADR (NASDAQ:GWPH) a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to Sativex(R) for the treatment of pain in patients with advanced cancer, who experience inadequate analgesia during optimized chronic opioid therapy. Sativex is currently in Phase 3 clinical trials for this indication. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares moved up 5.02% in last trading session and was closed at $65.24 while trading in range of $61.48 – $69.00 – GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) year to date (YTD) performance is 57.05%.
Haemonetics Corporation (NYSE:HAE) announced that its Board of Directors has approved the repurchase of up to $100 million of shares, consistent with its loan covenants. In approving the repurchase, the Board acknowledged the company’s strong cash flow and $192 million cash balance. Haemonetics Corporation (NYSE:HAE) weekly performance is -6.08%. On last trading day company shares ended up $31.19. Haemonetics Corporation (NYSE:HAE) distance from 50-day simple moving average (SMA50) is -11.21%. Analysts mean target price for the company is $40.44.